Can Liver Problems Cause Shortness of Breath?

Liver disease can absolutely cause shortness of breath, and it does so through several distinct pathways. Some involve the liver failing to clear substances that then damage or reshape the blood vessels in the lungs. Others are more mechanical, like abdominal fluid pressing upward against the diaphragm. In one study of patients with end-stage liver disease, 88% reported some degree of chronic breathlessness. The relationship between the liver and the lungs is more intimate than most people realize, and the breathing problems that result range from mildly annoying to life-threatening.

Hepatopulmonary Syndrome

The most specific liver-to-lung condition is hepatopulmonary syndrome, or HPS. It develops when chronic liver disease or high pressure in the portal vein system triggers the tiny blood vessels inside the lungs to dilate abnormally. These widened vessels allow blood to pass through the lungs too quickly, without picking up enough oxygen along the way. The result is a growing mismatch between how much air you breathe in and how much oxygen actually reaches your bloodstream.¹ Some blood effectively bypasses the oxygen-exchange areas of the lung entirely through shunts.

HPS has a characteristic clinical signature. The hallmark symptom is something called platypnea-orthodeoxia, which in plain terms means you feel more breathless when you stand up than when you lie down. That pattern is the opposite of what happens in heart failure, where lying flat makes breathing harder. It occurs because gravity pulls more blood into the dilated vessels at the base of the lungs when you’re upright, worsening the oxygen deficit. In one study of cirrhotic patients with HPS, every single patient reported dyspnea, and 90% had visible cyanosis, a bluish tinge to the skin or lips from low oxygen.² Clubbing of the fingertips, where the nails curve and the fingertips widen, was the most specific physical sign pointing toward an HPS diagnosis.

What makes HPS tricky is that it can develop regardless of how severe the liver disease appears on standard measures. The degree of liver dysfunction does not always predict who gets it. HPS occurs because of portal hypertension and the liver’s failure to clear certain vasoactive substances, chemicals that influence blood vessel tone and which are normally metabolized in the liver.³ When these substances spill into the general circulation, they cause the pulmonary vessels to relax and widen in ways they were never meant to.

Portopulmonary Hypertension

Portopulmonary hypertension, or POPH, is in some ways the mirror image of HPS. Rather than the lung blood vessels dilating, they constrict and remodel. The walls of the small pulmonary arteries thicken, the vessels narrow, and pressure inside the lungs rises. The heart’s right ventricle, which pumps blood to the lungs, has to work harder and harder against this resistance. Over time, right-sided heart failure can develop.⁴

The underlying trigger is similar to HPS in that the liver’s inability to clear vasoactive substances from the portal circulation is central. But the downstream effect on the lungs is opposite: where HPS opens vessels too wide, POPH narrows and stiffens them. The structural changes in the pulmonary arteries in advanced POPH resemble what happens in primary pulmonary hypertension that has nothing to do with the liver at all.⁵

Symptoms include progressive shortness of breath during exertion, fatigue, chest pain, and sometimes fainting. Because these symptoms overlap heavily with many other conditions, POPH is often not recognized until it has advanced. It matters a great deal for patients being evaluated for liver transplant, since uncontrolled high pulmonary pressure makes surgery far more dangerous.

Fluid Buildup and the Diaphragm

Not all liver-related breathing trouble comes from changes inside the lungs’ blood vessels. Sometimes the problem is simply mechanical. Cirrhosis commonly leads to ascites, the accumulation of fluid in the abdominal cavity. A large volume of fluid pushes the diaphragm upward, compressing the lungs from below and reducing how much they can expand when you try to breathe in. The effect is most pronounced when you’re lying flat.

Draining that fluid can make a dramatic difference. In cirrhotic patients who underwent paracentesis (a procedure where a needle is used to drain abdominal fluid), the pressure inside the abdomen dropped roughly in half, and the oxygen-to-air ratio improved substantially. Lung volume at the end of a normal exhale increased by an average of about 460 mL, roughly a full cup’s worth of space the lungs regained to work with.⁶ The relief is real but temporary if the underlying liver disease keeps producing more fluid.

A related condition is hepatic hydrothorax, where ascitic fluid migrates directly from the abdominal cavity into the space around one of the lungs. This happens through tiny defects in the diaphragm, usually less than a centimeter across. About 85% of the time, the fluid ends up on the right side. The movement is one-directional: the negative pressure inside the chest during breathing acts like a vacuum, pulling fluid up through the defect, while the positive pressure in the abdomen pushes it from below.⁷ Hepatic hydrothorax can cause severe breathlessness even in the absence of large-volume ascites visible in the abdomen, because relatively small amounts of fluid in the pleural space are very effective at collapsing lung tissue.

When the Heart Gets Involved

Cirrhosis doesn’t just affect the lungs; it reshapes how the heart works too. Cirrhotic cardiomyopathy, a form of heart dysfunction driven by liver disease, is present in roughly half of all patients with cirrhosis.⁸ It manifests as weakened heart contractions, stiffness of the heart during its relaxation phase, and an overdriven circulatory system that keeps heart rate and cardiac output chronically elevated. This combination means the heart can’t respond properly when demand increases, such as during physical activity or physiological stress. Shortness of breath during exertion is a common result.

Cirrhotic cardiomyopathy often goes unrecognized because the resting heart looks reasonably normal on standard tests. The dysfunction becomes apparent only when the heart is challenged. It can also worsen breathing problems caused by the other mechanisms described above, since a poorly functioning heart makes it harder for the lungs to clear fluid efficiently.

Muscle Wasting and Breathing Effort

Advanced liver disease frequently causes widespread muscle wasting, a condition known as sarcopenia. Most discussions of sarcopenia focus on the skeletal muscles of the arms and legs, but the same process affects the respiratory muscles: the diaphragm and the intercostal muscles that expand the ribcage. When these muscles weaken, the physical act of breathing becomes harder even if the lungs and heart are functioning adequately.

In a study of 40 patients with end-stage liver disease, roughly a third had respiratory muscle strength below normal limits. The weaker the breathing muscles, the worse the patient’s chronic breathlessness. Patients with ascites had significantly weaker respiratory muscles than those without, suggesting that muscle wasting and mechanical compression compound each other.⁹ This is a finding that should matter more than it currently does in clinical practice: breathlessness in cirrhosis is often attributed only to fluid or shunting, while the contribution of muscle weakness gets overlooked.

The muscle loss in cirrhosis is not just from inactivity. It reflects a systemic metabolic disturbance involving altered protein synthesis, chronic inflammation, and changes in how the body uses energy. Sarcopenia in cirrhosis affects muscles of vital organs, including the heart and respiratory system, and is increasingly recognized as a driver of poor outcomes beyond what traditional liver disease severity scores predict.¹⁰

Conditions That Damage Both the Liver and the Lungs

Sometimes the liver and lungs aren’t connected by one causing problems in the other but rather by a shared cause hitting both organs at once. Alpha-1 antitrypsin deficiency is the clearest example. It’s a genetic condition in which the body produces a misfolded version of a protective protein. The abnormal protein accumulates in liver cells, causing inflammation, scarring, and eventually cirrhosis. Meanwhile, the absence of the normal protein in the bloodstream leaves the lungs unprotected against damage from immune enzymes, leading to early-onset emphysema.¹¹ The condition affects roughly 1 in 2,000 to 1 in 5,000 people and is widely underdiagnosed.¹² A patient showing up with both unexplained liver disease and early lung disease should prompt testing for this deficiency, yet many go years without a diagnosis.

Certain medications also target both organs. Amiodarone, a commonly used heart rhythm drug, is well known to cause pulmonary toxicity that presents as interstitial lung disease with progressive breathlessness. Less appreciated is that it can simultaneously cause severe liver injury. Case reports describe patients developing diffuse lung inflammation and significant liver damage concurrently after months on the drug.¹³ In these situations the breathlessness isn’t the liver affecting the lungs or vice versa; it’s a toxic exposure damaging both organs on parallel tracks.

Obstructive sleep apnea offers yet another shared-cause scenario. The repeated drops in blood oxygen during sleep appear to promote fatty liver disease, while the sleep apnea itself causes daytime breathlessness and fatigue.¹⁴ Obesity ties these conditions together, as it independently raises the risk of both. In patients with metabolic syndrome, breathing trouble and liver abnormalities often coexist without one directly causing the other.

Liver Disease and Acute Lung Injury

Chronic liver conditions get most of the attention, but acute liver dysfunction can also trigger respiratory crises. The liver plays a central role in clearing endotoxin (a bacterial product) and inflammatory mediators from the bloodstream. When the liver fails to perform this filtering function, during severe hepatitis, acute liver failure, or in the setting of sepsis in a cirrhotic patient, these substances flood the circulation and can damage the lung’s delicate gas-exchange membranes. Patients with liver disease are at high risk for developing acute respiratory distress syndrome (ARDS), a severe form of lung inflammation in which the lungs fill with fluid and become stiff.¹⁵ The combination of liver failure and ARDS carries a particularly grim prognosis.

How Doctors Figure Out What Is Going On

When a patient with known liver disease develops unexplained breathlessness, the diagnostic workup has to sort through all the potential mechanisms described above, sometimes several at once. One of the most useful screening tools for HPS is a contrast echocardiogram, sometimes called a “bubble study.” A saline solution with tiny microbubbles is injected into a vein. In a healthy person, those bubbles get trapped in the lung’s capillaries and never reach the left side of the heart. If the pulmonary vessels are abnormally dilated, the bubbles pass through and show up on the heart ultrasound after a short delay, confirming the presence of intrapulmonary shunting.¹⁶

The timing of the bubble appearance matters. Bubbles that appear on the left side of the heart within one to three heartbeats suggest a defect inside the heart itself, like a hole between chambers. Bubbles that appear after three to six heartbeats indicate the shunting is happening down in the lungs, which is the pattern seen in HPS.¹⁷ The test can be done through the chest wall or, for greater sensitivity, through a probe placed in the esophagus.¹⁸

Blood gas analysis rounds out the picture by measuring exactly how much oxygen is in the blood and calculating the gap between what the lungs should be delivering and what they actually are. If POPH is suspected, further workup involves measuring the pressures inside the pulmonary arteries directly. Standard pulmonary function tests and chest imaging help rule out other causes of breathlessness, such as underlying lung disease unrelated to the liver.

Treatment and Whether Breathing Improves

The treatment options depend entirely on which mechanism is causing the breathing trouble. For ascites-related compression, draining the fluid brings quick relief, as noted earlier, and ongoing management with diuretics and salt restriction can slow reaccumulation. Hepatic hydrothorax is trickier; repeated drainage carries risks, and procedures to close the diaphragmatic defects or place shunts to redirect blood flow away from the portal system are sometimes attempted, with variable success.

For HPS, the only definitive treatment is liver transplantation. No medication has proven reliably effective at reversing the pulmonary vascular dilation. The good news is that transplantation genuinely works. In a systematic review and meta-analysis, the pooled rate of HPS resolution was about 82% at three months and roughly 90% at six months after transplant. Some studies reported complete resolution in all transplanted patients by one year.¹⁹ Liver transplantation triples five-year survival in HPS patients compared to those who do not receive a transplant.²⁰

The recovery period can be rocky, though. Severe low oxygen levels right after transplant occur in roughly 6 to 21% of HPS patients and carry a mortality rate around 45%. These patients account for the majority of deaths around the time of surgery in this population.²¹ Survivors, however, do go on to fully normalize their oxygen levels over time. The perioperative risk is the price of a treatment that otherwise has no substitute.

POPH requires a different approach. Pulmonary vasodilator medications similar to those used in other forms of pulmonary hypertension can lower pressures and improve symptoms. If pressures can be brought under control, liver transplant may become safe enough to proceed. If POPH is severe and uncontrolled, transplant is generally too dangerous. Cirrhotic cardiomyopathy has no targeted therapy beyond managing the liver disease itself and being cautious with fluid balance. And for respiratory muscle weakness, there is limited evidence but some clinical logic behind pulmonary rehabilitation and nutritional support aimed at preserving muscle mass.

Why This Connection Gets Missed

One of the frustrating aspects of liver-related breathing trouble is how often it goes unrecognized. A patient with cirrhosis who complains of being short of breath may have the symptom attributed to deconditioning, anxiety, or age. Doctors who primarily manage liver disease may not think to evaluate the lungs, and pulmonologists seeing an unexplained oxygen problem may not connect it to the liver, especially if the liver disease is mild or not yet diagnosed. HPS in particular has no reliable way to be detected on a standard chest X-ray or routine blood test; the bubble study has to be specifically ordered. Alpha-1 antitrypsin deficiency remains widely underdiagnosed despite being one of the most common genetic conditions affecting both organs.

If you have known liver disease and are experiencing progressive breathlessness, worsening when standing, or low oxygen levels that don’t have an obvious explanation, it’s worth raising the possibility of a liver-lung connection with your doctor. A bubble echocardiogram, arterial blood gas, and review of your medications can go a long way toward sorting out the cause. The conditions described here are treatable to varying degrees, but only once someone recognizes what’s happening.